MedTrace Logo

Offering Cervical Cancer Screening to Older Women

NCT04114968 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2020-11-06

No results posted yet for this study

Summary

This study evaluates the effect and feasibility of expanding the target population in the Danish cervical cancer screening program to include women aged 65 to 69 years. The study also evaluates if HPV self-sampling constitutes an appropriate screening method among older women.

Conditions

  • Uterine Cervical Neoplasm
  • Uterine Neoplasm
  • Uterine Cervical Disease
  • Mass Screening

Interventions

OTHER

GP-based screening or HPV self-sampling

Women in the intervention group will receive an invitation for HPV-based cervical cancer screening by either 1) scheduling an appointment for a cervical cytology by the GP or 2) collect a cervico-vaginal sample themselves in their own home using a self-sampling kit.

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Mette T Tranberg, post doc phd · Randers Regional Hospital, Central Denmark Region

Eligibility

Min Age
65 Years
Max Age
69 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-30
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04114968 on ClinicalTrials.gov